An interview with Prof. Dr. Kerstin Stemmer about obesity, GLP-1 obesity drugs and her research research_������������_������app��Ͷע������

������������_������app��Ͷע������ of Augsburg
2025-05-14T11:00:00+00:00
Universit?t Augsburg

Obesity increases the risk of numerous secondary diseases such as type 2 diabetes, high blood pressure and mental illness. Prof. Dr. Kerstin Stemmer explains the role of genetics in weight loss and the effect of GLP-1 weight loss medication. She is researching the extent to which fat cells can communicate directly with the pancreas in order to stimulate insulin production.